Medicortex Finland is dedicated to improving the diagnostics, treatment and prevention of acute neurodegenerative conditions. Current focus is on developing a novel biomarker based diagnostic test for traumatic brain injuries (TBI). After the development project the company will focus on a multiplex treatment for TBI.



Tilivinkki Logo

Skaalattu Kolster.jpg

Innokas Medical Logo Jpeg

The company's auditors are PricewaterhouseCoopers (PwC).